I was just clarifying the process outlined at the AGM. The patient will always get scanned first by the standard of care and then the EMV scan will be secondary. Standard of care / approved and proven technology will always be used as a priority over a scan involved in a trial. The patient care comes first.
EMvision Research Notes, page-1914
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.01 |
Change
-0.060(2.90%) |
Mkt cap ! $171.8M | |||
| Open | High | Low | Value | Volume |
| $2.09 | $2.10 | $2.01 | $39.56K | 19.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5069 | $2.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.17 | 4000 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| EMV (ASX) Chart |